Ikarian Capital »

Biomx shares owned by Ikarian Capital

Quarter-by-quarter ownership of Biomx (PHGE) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Biomx

Tip: Access up to 7 years of quarterly data

All positions including Biomx held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomx by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $36k 20k 1.87

More positions owned by Ikarian Capital

Cidara Therapeutics Com New (CDTX)
Spdr Series Trust State Street Spd Put Option (XBI)
Amgen (AMGN)
Terns Pharmaceuticals (TERN)
Abivax Sa Sponsored Ads (ABVX)
Harrow Health (HROW)
Rapt Therapeutics Com New (RAPT)
Cytokinetics Com New (CYTK)
Jazz Pharmaceuticals Call Call Option
Soleno Therapeutics (SLNO)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Maze Therapeatics (MAZE)
Omeros Corporation Call Option (OMER)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)

View all positions for Ikarian Capital

Top funds holding Biomx

Deerfield Management Company
Nantahala Capital Management
Ikarian Capital
UBS Group
Barclays
SBI Securities
CWM
Danske Bank A/s

View all funds holding Biomx